Clinical Data Management Systems (CDMS) Market Analysis

Clinical Data Management Systems Market Analysis

Based on delivery mode, the clinical data management systems market is classified into licensed enterprise (on-premise) solutions, cloud based (SaaS) solutions, and web-hosted (on-demand) solutions. The cloud-based (SaaS) solution segment held highest market share of 55.6% in 2022. The high segmental growth is attributed to technological developments in the healthcare sector and rising adoption of cloud-based solutions.
 

• The cloud-based model offers various advantages such as flexibility, collaboration, and scalability, among others. Such advantages associated with cloud-based solution will foster the market progression.
   
• Additionally, the cloud-based model also eliminates the need for purchasing, maintaining, and deploying on-premises services, thus reducing installation and maintenance cost, thereby contributing to the market size.
   

Based on end-use, the clinical management data system market is segmented into contract research organization (CROs), medical device companies, pharma/biotech companies and others. The contract research organization (CRO) segment is expected to register a higher growth rate of 11.7% during the forecast period.
 

• Growing number of contract research organizations (CROs) across the globe is expected to supplement the market growth. In addition, an increasing trend for outsourcing clinical trials to CROs, as it reduces the overall cost of drug development, is expected to further fuel the market trends.
   
• Further, clinical data management system (CDMS) along with electronic data capture (EDC) are one of the most prominent digital solutions adopted by several CROs to manage increasing volume of data. Thus, deployment of CDMS in several clinical research activities is anticipated to spur the market demand.
   

North America accounted for 45.9% of the global clinical data management systems market in 2022.
 

• North America is anticipated to retain its dominance throughout the forecast period owing to the strong foothold of prominent pharma & biopharmaceutical companies along with CROs.
   
• Moreover, wide-ranging drug development activities in North America is expected to further boost the usage of clinical data management system. Additionally, increasing clinical research studies in the U.S. and a paradigm shift from manual data collection & analysis to real-time data analysis while conducting clinical research is anticipated to spur the expansion of the market in the region.